Nath Bio-Genes (India) Ltd

Nath Bio-Genes (India) Annual General Meeting

Nath Bio-Genes (India) Ltd held its 33rd AGM on September 24, 2026. Shareholders approved all five resolutions, including a final dividend of ₹2/- per share.

Nath Bio-Genes (India) Annual General Meeting

Nath Bio-Genes (India) Ltd issued notice for its 33rd Annual General Meeting, to be held on September 24, 2026, alongside the Annual Report for FY2025-26.

Nath Bio-Genes (India) ED Probe / Tax Survey

SEBI has initiated a forensic audit of Nath Bio-Genes (India) Ltd for financial years 2020-21 to 2025-26. CNK & Associates LLP has been appointed as the forensic auditor.

Execution

FY 2020-21 to 2025-26

Nath Bio-Genes (India) Investor Presentation: Key Takeaways

Nath Bio-Genes reported strong Q1 FY27 results with Revenue and EBITDA growing 15% and 17% YoY respectively. The company continues to focus on high-yield cotton, maize, and paddy seeds.

Nath Bio-Genes (India) Q1 FY27 Results: Net Profit ₹32.3 Cr, Up 14.1% YoY

Nath Bio-Genes (India) Ltd reported revenue from operations of ₹328.4 Cr (+15.8% YoY) and net profit of ₹32.3 Cr (+14.1% YoY) for Q1 FY27.

Key figure

Net profit ₹32.3 Cr · +14.1% YoY

Nath Bio-Genes (India) Other Announcement

Nath Bio-Genes (India) Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b). This disclosure provides the updated distribution of shareholding across various investor categories.

Nath Bio-Genes (India) Board Meeting Date

Nath Bio-Genes (India) Ltd has scheduled a board meeting for 29th July 2026 to consider and approve its unaudited financial results for the June quarter.